Browsing INIBIC-ICATC - Congresos, conferencias, etc. by Title

Now showing items 4-8 of 8

Determinants and prognostic value of peak oxygen uptake in the current era of heart failure disease modifying therapy

Roibal-Pravio, J.; Barge-Caballero, Eduardo; Paniagua-Martín, María J.; Barge-Caballero, Gonzalo; Couto-Mallón, David; Martínez-Ruiz, D.; Fábregas-Casal, R.; Blanco-Canosa, Paula; Naya, Carmen; Riveiro-Rodríguez, C.M.; Grille Cancela, Zulaika; Costa-Grana, C.M.; Pérez-Fernández, R.; Vázquez Rodríguez, José Manuel; Crespo-Leiro, María Generosa (Wiley, 2017-05-01)
Dopamine is associated with the worst outcome among inotropes used in acute heart failure: observations from the ESC-HF-LT registry

Mebazaa, Alexandre; Motiejunaite, J.; Gayat, Etienne; Akiyama, Eiichi; Crespo-Leiro, María Generosa; Lund, Lars H.; Maggioni, Aldo P.; Chioncel, Ovidiu; Ruschitzka, Frank; Filippatos, Gerasimos (Wiley, 2017)
Long term safety of inotropes and/or vasopressors in acute heart failure: results from ESC-HF-LT registry

Mebazaa, Alexandre; Motiejunaite, Justina; Gayat, Etienne; Akiyama, Eiichi; Crespo-Leiro, María Generosa; Lund, Lars H.; Maggioni, Aldo P.; Chioncel, Ovidiu; Ruschitzka, Frank; Filippatos, Gerasimos (Wiley, 2017)
One-year outcome in patients with heart failure with mid-range ejection fraction hospitalized due to worsening heart failure

Marchel, Michal; Tyminska, Agata; Kaplon-Cieslicka, Agnieszka; Ozieranski, Krzysztof; Peller, Michal; Balsam, Pawel; Crespo-Leiro, María Generosa; Maggioni, Aldo P.; Drozdz, Jaroslaw; Filipiak, Krzysztof J.; Opolski, Grzegorz (2017)
Predictors of optimal pharmacological treatment in patients with heart failure and depressed ejection fraction. Results of the VIDA-IC study

Hidalgo Lesmes, Francisco José; Anguita, Manuel; Comín, Josep; Muñiz, Javier; Crespo-Leiro, María Generosa; Formiga, Francesc; Manzano, Luis; Almenar-Bonet, Luis; Frutos, Trinidad de (Wiley, 2015)

Browsing INIBIC-ICATC - Congresos, conferencias, etc. by Title

Determinants and prognostic value of peak oxygen uptake in the current era of heart failure disease modifying therapy ﻿

Dopamine is associated with the worst outcome among inotropes used in acute heart failure: observations from the ESC-HF-LT registry ﻿

Long term safety of inotropes and/or vasopressors in acute heart failure: results from ESC-HF-LT registry ﻿

One-year outcome in patients with heart failure with mid-range ejection fraction hospitalized due to worsening heart failure ﻿

Predictors of optimal pharmacological treatment in patients with heart failure and depressed ejection fraction. Results of the VIDA-IC study ﻿

Determinants and prognostic value of peak oxygen uptake in the current era of heart failure disease modifying therapy

Dopamine is associated with the worst outcome among inotropes used in acute heart failure: observations from the ESC-HF-LT registry

Long term safety of inotropes and/or vasopressors in acute heart failure: results from ESC-HF-LT registry

One-year outcome in patients with heart failure with mid-range ejection fraction hospitalized due to worsening heart failure

Predictors of optimal pharmacological treatment in patients with heart failure and depressed ejection fraction. Results of the VIDA-IC study